We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A scientist pipetting into an assay plate.

AI Method Accelerates Drug Discovery for Parkinson’s 10-Fold, Study Finds

A purple human brain.

Antipsychotic Use in Dementia Linked to Elevated Health Risks

Umbrella-shaped antibacterial toxin particles drifting toward and engaging a bacterial target cell.

Soil Bacteria Produce Unique Antimicrobial Particles

Study Investigates Links Between HIV Drugs and Reduced Alzheimer’s Disease Incidence

Scientists Pinpoint Brain Region Crucial for Attention Control

Targeted Liver Cancer Treatment May Help Cut Side Effects

News

Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells

New drug prevents tumour growth by inhibiting the nucleotide sanitizing enzyme MTH1.

Sony DADC to Enter Into a Manufacturing Agreement with Trinean

Sony DADC to supply microfluidic disposables for Trinean’s high throughput DropSense96™ spectrometers and its Xpose™ Touch & Go sample QC analyzer.

BioAlliance Pharma Collaborates with Penn Pharma

Collaboration on the industrial development of Validive®.

Charles River Laboratories Completes Acquisition of Galapagos’ CRO Services

Acquisition is expected to add approximately 6% to Company’s net sales in 2014.

Aspirin Does Not Prevent Pregnancy Loss, NIH Study Finds

Increased live birth rate in subgroup of participants.

Steve McCairns Joins Expanding PCI Team as UK Director of Operations

Company also provides global storage and distribution services for clinical trial materials.

Cobra Biologics Granted Approval for Research Tax Credit

Company has recognized as an approved service provider for the period 2013 to 2015.

UCB CEO to Chair IMI Board for a Second Term

Roch Doliveux to spearhead industry’s commitment to world’s biggest public-private partnership in biopharmaceutical research and innovation.

Spectral Announces Fourth Quarter and Fiscal 2013 Results

Company announces fourth quarter highlights and financial review.

e-Therapeutics Reports Positive Interim Results from UK Phase Ia Trial of ETS2101

ETS2101 well tolerated at all six dose escalations with no serious adverse events attributed to the drug.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter